Feasibility, timing and outcome of leadless cardiac pacemaker implantation in patients undergoing cardiac implantable electronic device extraction. Posted on September 17th, 2024 by LEADconnection Post navigation Previous: Cardiac implantable electronic device infection awareness – A European survey amongst implanting physiciansNext: Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience.
Cardiac implantable electronic device infection awareness – A European survey amongst implanting physicians Posted on September 17th, 2024 by Betsy Stovsky Post navigation Previous: FDA approves Biotronik lead, catheter for left bundle branch area pacingNext: Feasibility, timing and outcome of leadless cardiac pacemaker implantation in patients undergoing cardiac implantable electronic device extraction.
Indications for Lead Extraction Posted on September 11th, 2024 by LEADconnection Post navigation Previous: Selection of candidates for cardiac resynchronization therapy and implantation management: an Italian survey promoted by the Italian Association of Arrhythmology and Cardiac Pacing.Next: BIOTRONIK Receives FDA Approval for LBBAP Indication on Pacing Lead and Delivery Catheter System